Lataa...
The benefits of statin therapy—what questions remain?
Early hydroxymethylglutaryl‐CoA reductase inhibitor (statin) trials provided the first evidence of the benefits of statin therapy in secondary prevention of coronary heart disease (CHD). Outcomes data from more recent trials involving atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastat...
Tallennettuna:
| Julkaisussa: | Clin Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Periodicals, Inc.
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654705/ https://ncbi.nlm.nih.gov/pubmed/16450792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960281103 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|